When infection, trauma, or surgery tilts the body into systemic inflammatory response, every minute counts. SJP-100 is engineered for rapid IV or oral deployment inside the hospital. By calming mast-cell storms upstream, it aspires to curb the cytokine flood that drives sepsis, ARDS, or multi-organ failure—potentially cutting ICU days, ventilator dependence, and mortality without the high cost, immune compromise or lag of biologic therapies. PAIR-powered SJP-100 is designed to tamp the mast-cell storm fast, aiming to shorten ICU days, curb organ damage, and slash mortality.
